| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010495656 |
| P356 | DOI | 10.1007/S100960050001 |
| P698 | PubMed publication ID | 10706172 |
| P2093 | author name string | Collignon PJ | |
| Crump JA | |||
| P433 | issue | 1 | |
| P921 | main subject | catheterization | Q2312472 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Intravascular catheter-associated infections. | |
| P478 | volume | 19 |
| Q46885843 | (B1) Candida and mycotic infections |
| Q33404911 | A Candida albicans early stage biofilm detachment event in rich medium |
| Q61699967 | A comparative assessment of two conservative methods for the diagnosis of catheter-related infection in critically ill patients |
| Q53974520 | A multicenter study on central venous catheter-associated infections in Italy. |
| Q35127891 | A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes |
| Q41838405 | Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation |
| Q34932922 | Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells |
| Q39954846 | Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole |
| Q26830053 | All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease |
| Q41367852 | An effective and biocompatible antibiofilm coating for central venous catheter |
| Q37227837 | Antifungal therapy with an emphasis on biofilms |
| Q33466403 | Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer. |
| Q42545813 | Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance |
| Q44516466 | Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections |
| Q34747087 | Candida albicans forms biofilms on the vaginal mucosa |
| Q35044563 | Candida biofilms and their role in infection |
| Q30475833 | Candida biofilms: an update |
| Q37699331 | Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs |
| Q37836193 | Cell signals, cell contacts, and the organization of yeast communities |
| Q24805785 | Central venous catheter related infections: risk factors and the effect of glycopeptide antibiotics |
| Q46736780 | Characterization of switch phenotypes in Candida albicans biofilms |
| Q46902548 | Chemical composition, antimicrobial and antioxidant activities of the essential oil of Tibetan herbal medicine Dracocephalum heterophyllum Benth |
| Q35915352 | Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. |
| Q37739067 | Comparison of infection rates among ultrasound-guided versus traditionally placed peripheral intravenous lines. |
| Q42129565 | Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform |
| Q42413031 | Delayed processing of blood samples influences time to positivity of blood cultures and results of Gram stain-acridine orange leukocyte Cytospin test. |
| Q40180329 | Detection of catheter-related bloodstream infections by the differential-time-to-positivity method and gram stain-acridine orange leukocyte cytospin test in neutropenic patients after hematopoietic stem cell transplantation |
| Q37523933 | Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. |
| Q28477874 | Development of a high-throughput Candida albicans biofilm chip |
| Q33548720 | Dispersion as an important step in the Candida albicans biofilm developmental cycle |
| Q84409837 | Early diagnostic value of plasma PCT and BG assay for CRBSI after OLT |
| Q46428396 | Effect of different incubation atmospheres on the production of biofilm in methicillin-resistant Staphylococcus aureus (MRSA) grown in nutrient-limited medium. |
| Q36593530 | Efficacy of surface-generated nitric oxide againstCandida albicansadhesion and biofilm formation |
| Q47716383 | Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources |
| Q36422270 | From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms |
| Q37887512 | Fungal Biofilms: Relevance in the Setting of Human Disease |
| Q34160486 | Guidelines on timing in replacing peripheral intravenous catheters. |
| Q36094993 | High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development |
| Q58692848 | Host Defence against Bacterial Biofilms: “Mission Impossible”? |
| Q41711895 | Imidazolium salts as antifungal agents: strong antibiofilm activity against multidrug-resistant Candida tropicalis isolates. |
| Q35490098 | Importance of Candida-bacterial polymicrobial biofilms in disease |
| Q35791192 | In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis |
| Q31114513 | In vitro activity of caspofungin against Candida albicans biofilms. |
| Q46110287 | In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms |
| Q33962613 | In vitro damage of Candida albicans biofilms by chitosan |
| Q39657947 | In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. |
| Q35960782 | In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters |
| Q41508451 | Inhibition of Candida albicans adhesion on medical-grade silicone by a Lactobacillus-derived biosurfactant |
| Q39661623 | Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule |
| Q34024546 | Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents |
| Q51204296 | Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. |
| Q35065279 | Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial). |
| Q45138122 | Involvement of curli fimbriae in the biofilm formation of Enterobacter cloacae |
| Q40604477 | Lipopeptides from Bacillus subtilis AC7 inhibit adhesion and biofilm formation of Candida albicans on silicone |
| Q38109647 | Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro |
| Q33721560 | Microbiological pattern of arterial catheters in the intensive care unit |
| Q37511316 | Microevolution of Candida albicans strains during catheter-related candidemia |
| Q39048545 | Non-culture based diagnostics for intravascular catheter related bloodstream infections |
| Q81199659 | Nonuniform risk of bloodstream infection with increasing central venous catheter-days |
| Q24198073 | Optimal timing for intravascular administration set replacement |
| Q37622959 | Our current understanding of fungal biofilms |
| Q24601191 | Pathogenesis and treatment of oral candidosis |
| Q37809056 | Preventing catheter-related infections in children undergoing hemodialysis. |
| Q37544805 | Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine |
| Q41524974 | Promoting safe IV management in practice using H.A.N.D.S. |
| Q33422347 | Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans |
| Q99239226 | Recent advances in topical carriers of anti-fungal agents |
| Q35667552 | Role of SFP1 in the Regulation of Candida albicans Biofilm Formation |
| Q36895701 | Role of oxylipins and other lipid mediators in fungal pathogenesis |
| Q59302093 | Separation of similar yeast strains by IEF techniques |
| Q37734438 | Sexual biofilm formation in Candida tropicalis opaque cells |
| Q28534755 | Soybean toxin (SBTX) impairs fungal growth by interfering with molecular transport, carbohydrate/amino acid metabolism and drug/stress responses |
| Q33982871 | Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms |
| Q34253859 | Sub-MICs of Carum copticum and Thymus vulgaris influence virulence factors and biofilm formation in Candida spp |
| Q58037544 | Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens |
| Q33322938 | Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing |
| Q33798459 | Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms |
| Q53452024 | Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users. |
| Q46790530 | Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm |
| Q36683547 | The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia |
| Q43246060 | The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation |
| Q40138692 | The prevalence of peripheral intravenous cannulae and pattern of use: A point prevalence in a private hospital setting. |
| Q87724710 | The role of Mss11 in Candida albicans biofilm formation |
| Q34177651 | The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion |
| Q45936716 | Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. |
| Q35685622 | Treatment failures in patients with ventilator-associated pneumonia |
| Q35666609 | Vancomycin and maltodextrin affect structure and activity of Staphylococcus aureus biofilms |
| Q90682818 | What are the advantages of living in a community? A microbial biofilm perspective! |
| Q74370058 | Yeasts isolated from blood and catheter in children from a public hospital of São Paulo, Brazil |
Search more.